Retirement Wealth Solutions’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.7K Buy
203
+22
+12% +$1.01K ﹤0.01% 302
2026
Q2
$8.68K Buy
181
+16
+10% +$687 ﹤0.01% 247
2026
Q1
$6.06K Sell
165
-11
-6% -$521 ﹤0.01% 286
2025
Q4
$8.96K Sell
176
-30
-15% -$1.53K 0.01% 237
2025
Q3
$11.4K Buy
206
+134
+186% +$7.84K 0.01% 213
2025
Q2
$4.97K Sell
72
-6
-8% -$408 ﹤0.01% 299
2025
Q1
$5.42K Hold
78
– – ﹤0.01% 278
2024
Q4
$6.73K Buy
+78
New +$8.44K 0.01% 271

Other funds holding NVO

Retirement Wealth Solutions's NVO Position: Q3 2026 in Review

Retirement Wealth Solutions increased its Novo Nordisk (NVO) stake by 12% in Q3 2026, buying an estimated $1.01K and bringing the position to 203 shares worth $7.7K. The position accounts for ﹤0.01% of the portfolio, ranked #302.

Retirement Wealth Solutions first reported a position in NVO in Q4 2024 and has held it in 8 quarters since. The position peaked at $11.4K in Q3 2025. 64 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

  • Retirement Wealth Solutions held 203 shares of Novo Nordisk worth $7.7K as of Q3 2026.
  • Retirement Wealth Solutions bought 22 Novo Nordisk shares in Q3 2026, an estimated $1.01K.
  • Novo Nordisk made up ﹤0.01% of Retirement Wealth Solutions's portfolio in Q3 2026, its #302 holding.
  • Retirement Wealth Solutions first reported a position in Novo Nordisk in Q4 2024 and has held it in 8 quarters since.
  • Retirement Wealth Solutions's Novo Nordisk position peaked at $11.4K in Q3 2025.
  • 64 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Retirement Wealth Solutions's 13F filing for Q3 2026, filed 7 Oct 2026.